479 filings
4
PCSA
Processa Pharmaceuticals Inc
12 Apr 24
Processa Pharmaceuticals / David Young ownership change
5:01pm
4
James H Stanker
12 Apr 24
Processa Pharmaceuticals / James H Stanker ownership change
4:57pm
4
Patrick Lin
12 Apr 24
Processa Pharmaceuticals / Patrick Lin ownership change
4:55pm
4
Sian Bigora
12 Apr 24
Processa Pharmaceuticals / Sian Bigora ownership change
4:52pm
4
Wendy Guy
12 Apr 24
Processa Pharmaceuticals / Wendy Guy ownership change
4:50pm
8-K
0lcucvq8t8i9
11 Apr 24
Regulation FD Disclosure
8:00am
8-K
l8u8c051ol3
4 Apr 24
Regulation FD Disclosure
12:05pm
8-K
3xravyw0 ifu
21 Feb 24
Regulation FD Disclosure
5:25pm
4
o9tx54vxmk89h6m0l3s
8 Feb 24
Processa Pharmaceuticals / David Young ownership change
4:30pm
4
x7b86a8
7 Feb 24
Processa Pharmaceuticals / David Young ownership change
4:22pm
8-K
maim 9q9j
6 Feb 24
Other Events
8:30am
4
dj905
1 Feb 24
Processa Pharmaceuticals / Patrick Lin ownership change
6:32pm
4
ihhhhyq gakva6cb
31 Jan 24
Processa Pharmaceuticals / George K Ng ownership change
4:37pm
4
5l4aoe01
31 Jan 24
Processa Pharmaceuticals / Justin W Yorke ownership change
4:34pm
8-K
lw4iy4y 1g8d7buph
30 Jan 24
Processa Pharmaceuticals Announces Pricing of $7.0 Million Public Offering
10:46am
424B4
hg9clebeq8yniwbk3e
29 Jan 24
Prospectus supplement with pricing info
4:15pm
EFFECT
5y54bzvkw 7ag000
29 Jan 24
Notice of effectiveness
12:15am
8-K
phc7orjv28y xol63p
25 Jan 24
NGC-Cap was better tolerated with positive preliminary efficacy results than FDA-approved capecitabine
8:35am
CORRESP
hp1d817ljc5wbw8q9
22 Jan 24
Correspondence with SEC
12:00am